Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?

Authors: Marchioni M.; Amparore D.; Marandino L.; Bertolo R.; Erdem S.; Ingels A.; Muselaers S.; Kara O.; Pavan N.; Roussel E.; Carbonara U.; Pecoraro A.; Diana P.; Pecoraro A.; Campi R.
Publication year: 2022
Type: Nota o commento
OA Link: http://hdl.handle.net/10447/662496